Four of the seven CF subjects whose macrophages were used for cytokine studies were taking prescribed CFTR modulator therapy at the time of phlebotomy [lumacaftor/ivacaftor (n = 3) or tezacaftor/ivacaftor (n = 1)]. This evidence concerns the gene CFTR and cystic fibrosis.